SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

TuHURA Biosciences, Inc. (HURA) News

Follow TuHURA Biosciences, Inc. (HURA) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol HURA Asset equity Sector Markets 90 days 3 Last 1.25 Updated Oct 26, 2026, 11:33 AM UTC Open live news feed Open HURA chart & news
L TuHURA reports partial tumor remissions in first three patients TuHURA reported partial tumor remissions in the first three patients in a study of IFx-2.0 with Keytruda. EQUITY | Oct 26, 2026, 11:33 AM UTC L TuHURA Biosciences Receives New U.S. Patent for TBS-2025 The patent broadens coverage for the company’s VISTA inhibitor, TBS-2025. EQUITY | Oct 13, 2026, 11:46 AM UTC L HURA - TuHURA Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference HURA - TuHURA Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference EQUITY | Sep 08, 2026, 11:45 AM UTC L TuHURA Biosciences reports second-quarter 2026 financial results TuHURA Biosciences (HURA) reports second-quarter 2026 financial results and provides a corporate update, according to TradeXchange Newsdesk. EARNINGS | Aug 14, 2026, 11:45 AM UTC